INTRODUCTION
Currently, coronavirus disease 2019 pandemic caused more than one million of deaths worldwide, with more than 54 million of confirmed cases in less than one year. Individuals with malignancies are considered high risk patients for bacterial, fungal, and viral infections.
To date a few data are available on the real incidence and outcome of COVID-19 in patient with chronic lymphocytic leukaemia1,2. An Italian survey involving 33 haematology centres with at least 100 patients per centres and involving 9930 CLL patients showed that less than 0.5% (47/9930) were found positive to COVID-19 3.